Sparsh Bio-tech Private Limited — Amoxicillin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Amoxicillin · $6.5M export value · DGFT Verified
Sparsh Bio-tech Private Limited is the #11 Indian exporter of Amoxicillin with $6.5M in export value and 183 verified shipments. Sparsh Bio-tech Private Limited holds a 1.1% market share in Amoxicillin exports across 13 countries. The company exports 2 pharmaceutical products worth $17.0M across 1 therapeutic categories.
Sparsh Bio-tech Private Limited — Amoxicillin Export Profile: Buyers & Destinations
Where Does Sparsh Bio-tech Private Limited Export Amoxicillin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $4.2M | 159 | 54.8% |
| KENYA | $1.1M | 48 | 14.9% |
| GHANA | $842.0K | 49 | 10.9% |
| ANGOLA | $369.8K | 20 | 4.8% |
| MOZAMBIQUE | $248.0K | 8 | 3.2% |
| BURUNDI | $160.8K | 5 | 2.1% |
| MYANMAR | $109.7K | 7 | 1.4% |
| MADAGASCAR | $108.1K | 15 | 1.4% |
| PHILIPPINES | $97.3K | 6 | 1.3% |
| YEMEN | $83.6K | 4 | 1.1% |
Sparsh Bio-tech Private Limited exports Amoxicillin to 17 countries. The largest destination is TANZANIA accounting for 54.8% of Sparsh Bio-tech Private Limited's Amoxicillin shipments, followed by KENYA (14.9%) and GHANA (10.9%). These destinations reflect Sparsh Bio-tech Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amoxicillin from Sparsh Bio-tech Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SPARSH BIO-TECH HEALTHCARE PVT LTD | TANZANIA | $1.2M | 49 |
| SPARSH BIO-TECH HEALTHCARE PVT. LTD | TANZANIA | $880.3K | 21 |
| SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED | TANZANIA | $711.2K | 21 |
| TO THE ORDER OF ABSA BANK GHANA LTD | GHANA | $574.2K | 32 |
| M/S. KENTONS LIMITED | KENYA | $567.9K | 21 |
| GUJARAT | TANZANIA | $327.1K | 9 |
| PRINCE FARMA LDA | ANGOLA | $300.5K | 17 |
| TO THE ORDER OF NATIONAL BANK OF | TANZANIA | $243.9K | 8 |
| JEET PHARMACY T LIMITED | TANZANIA | $236.9K | 6 |
| TO THE ORDER OF ABSA BANK UGANDA | KENYA | $204.1K | 9 |
Sparsh Bio-tech Private Limited supplies Amoxicillin to 46 buyers globally. The largest buyer is SPARSH BIO-TECH HEALTHCARE PVT LTD (TANZANIA), followed by SPARSH BIO-TECH HEALTHCARE PVT. LTD (TANZANIA) and SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amoxicillin Export Value and How Much Does Sparsh Bio-tech Private Limited Contribute?
India exported $328.2M worth of Amoxicillin through 15,000 shipments from 633 suppliers to 161 countries, serving 2,055 buyers globally. Sparsh Bio-tech Private Limited contributes $6.5M to this total, accounting for 1.1% of India's Amoxicillin exports. Sparsh Bio-tech Private Limited ships Amoxicillin to 17 countries through 46 buyers.
What Is the Average Shipment Value for Sparsh Bio-tech Private Limited's Amoxicillin Exports?
Sparsh Bio-tech Private Limited's average Amoxicillin shipment value is $35.6K per consignment, based on 183 shipments totaling $6.5M. The largest destination is TANZANIA (54.8% of Sparsh Bio-tech Private Limited's Amoxicillin exports).
How Does Sparsh Bio-tech Private Limited Compare to Other Indian Amoxicillin Exporters?
Sparsh Bio-tech Private Limited ranks #11 among 633 Indian Amoxicillin exporters with a 1.1% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($96.1M), MICRO LABS LIMITED ($63.3M), MEDREICH LIMITED ($47.7M). Sparsh Bio-tech Private Limited processed 183 shipments to 13 destination countries.
What Amoxicillin Formulations Does Sparsh Bio-tech Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMOXICILLIN AND CLAVULANATE POTASSIUM TA | $520.9K | 22 |
| AMOXICILLIN CAPSULES BP 250 MG Total Net | $371.3K | 10 |
| AMOXICILLIN 500 MG AND CLAVULANATE POTAS | $369.0K | 8 |
| AMOXICILLIN CAPSULES BP 500 MG Total Net | $258.9K | 6 |
| AMOXICILLIN CAPSULES BP 250 MG TOTAL NETWEIGHT - 2188.672 KGS / PRICE PER KG 37.46557 USDPCS | $162.7K | 6 |
| AMOXICILLIN CAPSULES BP 500 MG BRAND NAM | $160.8K | 5 |
| AMOXICILLIN&CLAVULANATE POTASSIUM FOR OR | $156.6K | 7 |
| AMOXICILLIN CAPSULES BP 250 MG TOTAL NETWEIGHT - 4377.381 KGS / PRICE PER KG 37.46556 USDPCS | $145.6K | 3 |
| AMOXICILLIN 500 MG AND CLAVULANATE POTASSIUM 125 MG TABLETS USP TOTAL NET WEIGHT- 1806 KGS / PRICE PER KG 75.01667 USDPCS | $133.3K | 3 |
| AMOXICILLIN DISPERSIBLE TABLETS 250 MG T | $132.8K | 5 |
Sparsh Bio-tech Private Limited exports 191 distinct Amoxicillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMOXICILLIN AND CLAVULANATE POTASSIUM TA with 22 shipments worth $520.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Sparsh Bio-tech Private Limited Compare to Nearest Amoxicillin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MEDOPHARM | $7.3M | 147 | 24 | $50.0K |
| 9 | MEDOPHARM PRIVATE LIMITED | $7.3M | 145 | 16 | $50.0K |
| 11 | SPARSH BIO-TECH PRIVATE LIMITED ★ | $6.5M | 183 | 13 | $35.6K |
| 14 | MEDICO REMEDIES LIMITED | $5.3M | 108 | 13 | $48.7K |
| 10 | BIOMATRIX HEALTHCARE PRIVATE LIMITED | $5.0M | 100 | 8 | $50.0K |
Sparsh Bio-tech Private Limited ranks #11 among 633 Indian Amoxicillin exporters. Average shipment value of $35.6K compared to the market average of $518.4K. The closest competitors by value are MEDOPHARM and MEDOPHARM PRIVATE LIMITED.
Which Indian Ports Ship Amoxicillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,157 | 7.7% |
| NHAVA SHEVA SEA (INNSA1) | 1,133 | 7.6% |
| HYDERABAD ICD (INSNF6) | 926 | 6.2% |
| HYDERABAD ICD | 797 | 5.3% |
| BANGALORE ICD (INWFD6) | 717 | 4.8% |
| JNPT/ NHAVA SHEVA SEA | 695 | 4.6% |
| SAHAR AIR | 483 | 3.2% |
| BANGALORE ICD | 471 | 3.1% |
What Other Antibiotics Products Does Sparsh Bio-tech Private Limited Export?
Sparsh Bio-tech Private Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Sparsh Bio-tech Private Limited's Amoxicillin Exports
The current geopolitical climate presents significant challenges for Indian pharmaceutical exporters like Sparsh Bio-tech. Heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor have led major carriers to alter key trade routes, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes (livemint.com). This disruption is particularly concerning for time-sensitive shipments, such as pharmaceuticals, where delays can compromise product efficacy and safety.
Additionally, the U.S. has imposed tariffs on pharmaceutical imports, including those from India, as part of broader trade policies (pubtexto.com). These tariffs could erode the price competitiveness of Indian exporters like Sparsh Bio-tech in the U.S. market. Furthermore, the European Union's implementation of the Falsified Medicines Directive (FMD) imposes stringent serialization and traceability requirements. Compliance with these regulations necessitates significant investment in technology and processes, potentially straining resources for companies with limited product portfolios.
Sparsh Bio-tech Private Limited — Regulatory Compliance & Quality Standards
For Indian pharmaceutical exporters, adherence to international regulatory standards is paramount. Compliance with the U.S. Food and Drug Administration (FDA), the World Health Organization's Good Manufacturing Practices (WHO GMP), and the European Union's regulations is essential for market access. While specific compliance records for Sparsh Bio-tech are not publicly available, the company's focused product line may facilitate streamlined quality control processes. However, any lapses in compliance could have disproportionate effects, given the company's reliance on a narrow product range.
About Sparsh Bio-tech Private Limited
Sparsh Bio-tech Private Limited exports 2 products worth $17.0M. Beyond Amoxicillin, top products include Ampicillin. View the complete Sparsh Bio-tech Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amoxicillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amoxicillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sparsh Bio-tech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 338 individual customs records matching Sparsh Bio-tech Private Limited exporting Amoxicillin, covering 191 formulations to 17 countries via 46 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 161+ countries, 2,055+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amoxicillin Export Data from Sparsh Bio-tech Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sparsh Bio-tech Private Limited's Amoxicillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sparsh Bio-tech Private Limited
Full Company Profile →
2 products · $17.0M total trade · 1 categories
Amoxicillin Stats
Company Overview
Top Products by Sparsh Bio-tech Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sparsh Bio-tech Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amoxicillin. For current shipment-level data, contact TransData Nexus.